NCT06806111

Brief Summary

The goal of this clinical trial is to evaluate whether two different techniques for treating palatal wounds-sutures and cyanoacrylate bioadhesive-can influence postoperative morbidity, clinical healing, and soft tissue dimensional changes in patients undergoing epithelialized gingival graft harvesting from the palate. The main questions it aims to answer are: Does the use of cyanoacrylate bioadhesive reduce postoperative morbidity compared to sutures? Does the choice of wound treatment technique affect clinical healing and three-dimensional changes in soft tissues? Researchers will compare the sutures (control group) to the cyanoacrylate bioadhesive (test group) to determine if the bioadhesive leads to improved postoperative outcomes. Participants will: Undergo epithelialized gingival graft harvesting from the palate. Receive either sutures or cyanoacrylate bioadhesive for wound closure. Be monitored for postoperative morbidity, clinical healing, and soft tissue dimensional changes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2025Sep 2026

First Submitted

Initial submission to the registry

January 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 3, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

February 3, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

1.4 years

First QC Date

January 25, 2025

Last Update Submit

April 5, 2026

Conditions

Keywords

gingival graft harvestingwound healing agentpostoperative painpalatal healingpalatal volumetric changes

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain

    Minimum and maximum values \[0-100\] Higher scores mean worse outcome (more pain) A questionnaire will be prepared and handed to patients on the day of the surgery. Patients will be instructed to answer the questions at the same time of the day and refer only to the palatal wound. Postoperative pain will be assessed using a Visual Analog Score (VAS) at 1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks postoperatively.

    1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks

Secondary Outcomes (11)

  • Postoperative bleeding

    1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks.

  • Discomfort at eating

    1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks

  • Analgesic consumption

    during the first week

  • Oral Health Impact Profile 5 questionnaire (OHIP5)

    At 8 weeks

  • Epithelial gingival graft dimensions

    Per-operatively

  • +6 more secondary outcomes

Study Arms (2)

Suture

ACTIVE COMPARATOR

This is the control group. In this group, 5-0 non-resorbable suspensory mattress sutures will be anchored to the soft tissues apical to the palatal wound area (5-0 Polypropylene, Prolene, Ethicon, Johnson and Johnson, New Brunswick, NJ, USA).

Procedure: Suture

Cyanoacrylate bioadhesive

EXPERIMENTAL

This is the test group. In this group, several drops of a high-viscosity cyanoacrylate bioadhesive will be applied (Cuantum Oral Adhesive, Cuantum Medical Cosmetics S.L., Spain) to create a uniform adhesive layer. No sutures will be placed.

Procedure: Cyanoacrylate bioadhesive

Interventions

SuturePROCEDURE

Hemostatic sutures at the palatal donor site; 5-0 non-resorbable suspensory mattress sutures will be anchored to the soft tissues apical to the palatal wound area (5-0 Polypropylene, Prolene, Ethicon, Johnson and Johnson, New Brunswick, NJ, USA).

Suture

Several drops of a high-viscosity cyanoacrylate bioadhesive will be applied (Cuantum Oral Adhesive, Cuantum Medical Cosmetics S.L., Spain) to create a uniform adhesive layer.

Cyanoacrylate bioadhesive

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy individuals older than 18 years old;
  • Healthy periodontal status according to the AAP/EFP definition;
  • Full-mouth plaque (FMPS) and bleeding scores (FMBS) ≤ 20%;
  • No history of soft tissue harvesting.

You may not qualify if:

  • Pregnancy or lactation;
  • Self-reported smoking ≥10 cigarettes/day;
  • Metabolic diseases that negatively affect soft tissue healing (i.e., diabetes mellitus);
  • Any medication that may interfere with wound healing;
  • Removable maxillary prostheses;
  • Ongoing orthodontic therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Universitària d'Odontologia - UIC Barcelona

Barcelona, Sant Cugat Del Valles, 08195, Spain

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Sutures

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Fixation DevicesSurgical EquipmentEquipment and Supplies

Central Study Contacts

Lory Abrahamian, DDS, MSc, PhD Candidate

CONTACT

Gonzalo Blasi, DDS, MS, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 25, 2025

First Posted

February 3, 2025

Study Start

February 3, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

The IPD to be shared will include: * Demographic data (e.g., age, gender, relevant medical history) * Clinical outcome measures, including postoperative morbidity, pain scores, and healing assessments * Three-dimensional soft tissue measurements, obtained from digital scans or clinical evaluations * Treatment allocation and intervention details, without identifiable information

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
After publishing
Access Criteria
Researchers must submit a formal data request outlining the purpose of their study, the specific data required, and the intended use.

Locations